Yang M, Wang X, Peng M, Wang F, Hou S, Xing R
Nanomicro Lett. 2025; 17(1):157.
PMID: 39992547
PMC: 11850698.
DOI: 10.1007/s40820-025-01666-8.
Moskal J, Michalak S
Front Cell Neurosci. 2025; 19:1541885.
PMID: 39963115
PMC: 11830821.
DOI: 10.3389/fncel.2025.1541885.
Yang Z, Zhang T, Zhu X, Zhang X
Biomedicines. 2025; 13(1).
PMID: 39857625
PMC: 11761263.
DOI: 10.3390/biomedicines13010041.
Fan X, Chen M
Discov Oncol. 2024; 15(1):829.
PMID: 39714742
PMC: 11666858.
DOI: 10.1007/s12672-024-01685-8.
Liang B, Ding X, Yang S, Feng E
Braz J Med Biol Res. 2024; 57:e13961.
PMID: 38985083
PMC: 11249198.
DOI: 10.1590/1414-431X2024e13961.
Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution.
Liang T, Gu L, Kang X, Li J, Song Y, Wang Y
Cell Commun Signal. 2024; 22(1):333.
PMID: 38890642
PMC: 11184850.
DOI: 10.1186/s12964-024-01602-0.
Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles.
Kim S, Tang M, Lu T, Chih S, Li W
Brain Res. 2024; 1840:149045.
PMID: 38821335
PMC: 11323215.
DOI: 10.1016/j.brainres.2024.149045.
Predictive value of procollagen c-protease enhancer protein on the prognosis of glioma patients.
Yu L, Hu X, Zhu H
Heliyon. 2024; 10(6):e28089.
PMID: 38533063
PMC: 10963382.
DOI: 10.1016/j.heliyon.2024.e28089.
Lysophosphatidic Acid Receptor 3 Activation Is Involved in the Regulation of Ferroptosis.
Huang Y, Lin K, Chiang J, Chen W, Lee H
Int J Mol Sci. 2024; 25(4).
PMID: 38397002
PMC: 10889550.
DOI: 10.3390/ijms25042315.
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature.
Tonelotto V, Costa-Garcia M, OReilly E, Smith K, Slater K, Dillon E
Cell Death Discov. 2024; 10(1):70.
PMID: 38341410
PMC: 10858877.
DOI: 10.1038/s41420-023-01773-8.
Selenoprotein P expression in glioblastoma as a regulator of ferroptosis sensitivity: preservation of GPX4 via the cycling-selenium storage.
Zheng X, Toyama T, Siu S, Kaneko T, Sugiura H, Yamashita S
Sci Rep. 2024; 14(1):682.
PMID: 38182643
PMC: 10770386.
DOI: 10.1038/s41598-024-51259-5.
Compensative Resistance to Erastin-Induced Ferroptosis in GPX4 Knock-Out Mutants in HCT116 Cell Lines.
Adamiec-Organisciok M, Wegrzyn M, Cienciala L, Sojka D, Nackiewicz J, Skonieczna M
Pharmaceuticals (Basel). 2023; 16(12).
PMID: 38139836
PMC: 10747702.
DOI: 10.3390/ph16121710.
Risk model-guided identification of MTDH expression as a marker for ferroptosis induction therapy in head and neck squamous cell carcinoma.
Wang X, Gao Y, Miao R, Li L, Nanding A, Liu Y
Am J Cancer Res. 2023; 13(11):5236-5253.
PMID: 38058815
PMC: 10695774.
The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer.
Chen B, Zhao L, Yang R, Xu T
Front Genet. 2023; 14:1275154.
PMID: 38028615
PMC: 10665572.
DOI: 10.3389/fgene.2023.1275154.
Knockdown of HNRNPM inhibits the progression of glioma through inducing ferroptosis.
Wang J, Luo X, Liu D
Cell Cycle. 2023; 22(20):2264-2279.
PMID: 38016815
PMC: 10730218.
DOI: 10.1080/15384101.2023.2286782.
Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression.
Zhang Y, Wu X, Zhu J, Lu R, Ouyang Y
BMC Cancer. 2023; 23(1):1120.
PMID: 37978473
PMC: 10655456.
DOI: 10.1186/s12885-023-11637-0.
Classification of SLC family-related genes involved in ferroptosis predicts lung cancer prognosis and immunotherapy response.
Gao S, Gong G, Wang X, Gao X, Guo X, Luo Y
Sci Rep. 2023; 13(1):20032.
PMID: 37973895
PMC: 10654497.
DOI: 10.1038/s41598-023-47328-w.
Identification of the ferroptosis regulator HELLS with prognostic value for adrenocortical carcinoma based on integrated analysis and experimental validation.
Liu Z, Xie Y, Liu S, Shen S, Zhu Y, Gou Q
Gland Surg. 2023; 12(9):1251-1270.
PMID: 37842529
PMC: 10570968.
DOI: 10.21037/gs-22-736.
Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer.
Cheng T, Wu J, Zhu B, Gao H, Zheng L, Chen W
J Cancer Res Clin Oncol. 2023; 149(18):16779-16795.
PMID: 37728703
PMC: 10645672.
DOI: 10.1007/s00432-023-05423-5.
Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer.
Zhao L, You Z, Bai Z, Xie J
Front Oncol. 2023; 13:1171878.
PMID: 37152064
PMC: 10157233.
DOI: 10.3389/fonc.2023.1171878.